Risk of tramadol induces seizure following naloxone therapy: Systematic review and meta-analysis Tramadol induces seizure following naloxone therapy
Iranian Journal of Pharmaceutical Sciences,
Vol. 21 No. 1 (2025),
21 Bahman 2025
,
Page 419-429
https://doi.org/10.22037/ijps.v21i1.47559
Abstract
Tramadol overdose is a significant global health issue with a rising prevalence. Several studies have highlighted a notable occurrence of seizures in individuals experiencing tramadol overdose. The incidence of seizures following the administration of naloxone in patients with tramadol overdose remains a topic of debate. This systematic review and meta-analysis assessed the incidence of tramadol-induced seizures after the administration of naloxone in individuals who had overdosed on tramadol.
Our study conducted a comprehensive search across multiple medical databases to identify articles reporting tramadol-induced seizures following naloxone therapy. The search encompassed Cochrane Central Register of Controlled Trials, MEDLINE-PubMed, Scopus, Ovid, Embase, Springer, Web of Sciences, Science Direct, and PubMed, with all searches completed by November 30, 2023. Additionally, the search encompassed reference lists of included studies and gray literature sources such as dissertations, organizational publications, and websites to gather supplementary data. The analysis involved calculating pooled odds ratio for seizure incidence between groups based on subgroups related to tramadol abuse history, seizure history, and intubation needs using fixed-effect models and odds ratios for gender distribution using random-effect models, all with 95% confidence intervals (CI).
The results indicate a marginally elevated seizure risk in the naloxone group versus controls; however, this difference did not reach statistical significance (OR: 0.91, 95% CI: 0.63–1.31; p=0.62). Subgroup analyses based on previous seizure history and tramadol abuse revealed slight differences between the naloxone and control groups in these subgroups, leading to an overall odds ratio of 0.89, 95% CI: 0.64, 1.23, with a P-value of 0.48. Further subgroup analysis indicated no significant disparity between the two groups concerning the need for intubation (p=0.13) and male gender distribution (p=0.49).
In conclusion, the study suggests that the use of naloxone in patients with tramadol toxicity does not independently trigger seizures. Naloxone administration was not associated with an increased risk of intubation or seizures. However, the lack of randomized clinical trials in this area necessitates more robust investigations to draw definitive conclusions.
- Tramadol
- Naloxone
- Seizure
- Overdose
- Poisoning
How to Cite
References
Nakhaee, S., et al., Tramadol and the occurrence of seizures: a systematic review and meta-analysis. Critical reviews in toxicology, 2019. 49(8): p. 710-723.
Ryan, N.M. and G.K. Isbister, Tramadol overdose causes seizures and respiratory depression but serotonin toxicity appears unlikely. Clin Toxicol (Phila), 2015. 53(6): p. 545-50.
Spencer, M.R., M. Garnett, and A.M. Miniño, Drug overdose deaths in the United States, 2002-2022. 2024: US Department of Health and Human Services, Centers for Disease Control and ….
Vearrier, D. and O. Grundmann, Clinical pharmacology, toxicity, and abuse potential of opioids. The Journal of Clinical Pharmacology, 2021. 61: p. S70-S88.
Cheng, W., R.P.K. Lam, and C.K. Chan, Factors associated with seizure in tramadol overdose: a 12-year retrospective study in Hong Kong. Clinical Toxicology, 2022. 60(11): p. 1220-1226.
Babahajian, A., et al., Seizure Prevalence and Its Related Factors in Tramadol Intoxication; a Brief Report (BRIEF REPORT). 2019.
Murray, B.P., et al., Seizures in tramadol overdoses reported in the ToxIC registry: predisposing factors and the role of naloxone. Clinical toxicology, 2019. 57(8): p. 692-696.
Shadnia, S., et al., Recurrent seizures in tramadol intoxication: implications for therapy based on 100 patients. Basic & clinical pharmacology & toxicology, 2012. 111(2): p. 133-136.
Hassamal, S., et al., Tramadol: understanding the risk of serotonin syndrome and seizures. The American journal of medicine, 2018. 131(11): p. 1382. e1-1382. e6.
Raj, K., P. Chawla, and S. Singh, Neurobehavioral consequences associated with long term tramadol utilization and pathological mechanisms. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 2019. 18(10): p. 758-768.
Manouchehri, A., et al., Tramadol poisoning and its management and complications: a scoping review. Ann Med Surg (Lond), 2023. 85(8): p. 3982-3989.
Eizadi-Mood, N., et al., Does naloxone prevent seizure in tramadol intoxicated patients? Int J Prev Med, 2014. 5(3): p. 302-7.
Lagard, C., et al., Is naloxone the best antidote to reverse tramadol-induced neuro-respiratory toxicity in overdose? An experimental investigation in the rat. Clinical Toxicology, 2018. 56(8): p. 737-743.
Farzaneh, E., B. Mostafazadeh, and O. Mehrpour, Seizurogenic effects of low-dose naloxone in tramadol overdose. Iran J Pharmacol Therapeutics, 2012. 11(11): p. 6-9.
Lewis, R.G., Goldfrank's toxicologic emergencies. 2015: Ninth edition. Norwalk, Conn. : Appleton & Lange, [2015] ©2015.
Eizadi-Mood, N., et al., Risk of Seizure after Naloxone Therapy in Acute Tramadol Poisoning: A Systematic Review with Meta-Analysis. International Journal of Preventive Medicine, 2019. 10(1): p. 183.
Hussien, R. and M. Elguindy, Assessment of the role of naloxone in the prognosis of tramadol intoxicated patients. J Clin Toxicol, 2017. 7(366): p. 2161-0495.1000366.
Eizadi-Mood, N., et al., Does naloxone prevent seizure in tramadol intoxicated patients? International journal of preventive medicine, 2014. 5(3): p. 302.
Fichna, J., et al., The mu-opioid receptor-selective peptide antagonists, antanal-1 and antanal-2, produce anticonvulsant effects in mice. Prog Neuropsychopharmacol Biol Psychiatry, 2013. 40: p. 126-31.
Sturgeon, M.L., et al., The opioid antagonist naltrexone decreases seizure-like activity in genetic and chemically induced epilepsy models. Epilepsia Open, 2021. 6(3): p. 528-538.
Farzaneh, E., B. Mostafazadeh, and O. Mehrpour, Seizurogenic effects of low-dose naloxone in tramadol overdose. Iranian Journal of Pharmacology and Therapeutics, 2012. 11(1): p. 6-0.
Cowley, A., The seizurogenecity of naloxone in tramadol overdose. Journal of Paramedic Practice, 2012. 4(5): p. 272-276.
Raffa, R.B. and D.J. Stone, Jr., Unexceptional seizure potential of tramadol or its enantiomers or metabolites in mice. J Pharmacol Exp Ther, 2008. 325(2): p. 500-6.
Buajordet, I., et al., Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. European Journal of Emergency Medicine, 2004. 11(1): p. 19-23.
DeClementi, C., Chapter 104 - Prevention and treatment of poisoning, in Veterinary Toxicology (Second Edition), R.C. Gupta, Editor. 2012, Academic Press: Boston. p. 1361-1379.
Xia, W., et al., Toxicology of tramadol following chronic exposure based on metabolomics of the cerebrum in mice. Sci Rep, 2020. 10(1): p. 11130.
Farzaneh, E., et al., Comparing the Frequency of Seizure in Patients Intoxicated with Tramadol Treated with or without Naloxone. Journal of Isfahan Medical School, 2012. 30(197).
Spiller, H.A., et al., Prospective multicenter evaluation of tramadol exposure. Journal of toxicology: clinical toxicology, 1997. 35(4): p. 361-364.
Hassanian-Moghaddam, H., F. Farnaghi, and M. Rahimi, Tramadol overdose and apnea in hospitalized children, a review of 20 cases. Research in pharmaceutical sciences, 2015. 10(6): p. 544-552.
Marquardt, K.A., J.A. Alsop, and T.E. Albertson, Tramadol exposures reported to statewide poison control system. Annals of Pharmacotherapy, 2005. 39(6): p. 1039-1044.
net, A.C.o.M.T.i.a., Abstracts from the 2017 American College of Medical Toxicology (ACMT) annual scientific meeting. Journal of Medical Toxicology, 2017. 13(1): p. 3-46.
Okazi, A., et al., Occurrence and recurrence of seizures and related factors in patients with tramadol ingestion. Int J Med Toxicol Forensic Med, 2018. 8(3): p. 101-8.
Hassanian-Moghaddam, H., et al., Tramadol-induced apnea. The American Journal of Emergency Medicine, 2013. 31(1): p. 26-31.
- Abstract Viewed: 273 times
- IJPS_Volume21_Issue1_Pages419-429 Downloaded: 182 times